Publication Details
The Australian experience with switching to extended half-life factor VIII and IX concentrates: On behalf of the Australian Haemophilia Centre Directors' Organisation
Brennan Y, Parikh S, McRae S, Tran H
(2020), Haemophilia, 26(3), 529-35
DOI: 10.1111/hae.13970
Incidence of residual perfusion defects by lung scintigraphy in patients treated with rivaroxaban compared with warfarin for acute pulmonary embolism
Lim MS, Nandurkar D, Jong I, Cummins A, Tran H, Chunilal S
(2020), J THROMB THROMBOLYS, 49(2), 220-7
DOI: 10.1007/s11239-019-01944-4
Risk Stratification of Acute Pulmonary Embolism and Determining the Effect on Chronic Cardiopulmonary Complications: The REACH Study
Stevens H, Fang W, Clements W, Bloom J, McFadyen J, Tran H
(2020), TH Open, 40(1), e45-50
DOI: 10.1055/s-0040-1708558
Ischaemic stroke and transient ischaemic attack on anticoagulants: outcomes in the era of direct oral anticoagulants
Valente M, Leung S, Wu P, Oh DH, Tran H, Choi PMC
(2020), Intern Med J, 50(1), 110-3
DOI: 10.1111/imj.14652
Predicting the Risk of Recurrent Venous Thromboembolism: Current Challenges and Future Opportunities
Stevens H, Peter K, Tran H, McFadyen J
(2020), J Clin Med, 9(5), 1582
DOI: 10.3390/jcm9051582
Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Renal Impairment
Jang SM, Bahjri K, Tran H
(2020), Pharmacy (Basel), 8(1), 30
DOI: 10.3390/pharmacy8010030
Interlaboratory validation of apixaban levels in ex vivo patient samples using a chromogenic anti-factor Xa assay
Singh J, Ong DM, Ling V, Lim MS, Malan E, Servadei P, Wallis A, Kelsey G, Chunilal S, Tran H
(2020), Int J Lab Hematol, 42(1), e23-6
Utilization of a Transanal TME Platform to Enable a Distal TME Dissection En Bloc with Presacral Fascia and Pelvic Sidewall with Intraoperative Radiotherapy Delivery in a Locally Advanced Rectal Cancer: Advanced Application of taTME
Waters PS, Peacock O, Larach T, Lee JD, McCormick JJ, Chander S, Heriot AG, Warrier SK
(2020), J LAPAROENDOSC ADV S, 30(1), 53-7
DOI: 10.1089/lap.2019.0576
Pelvic Exenteration for Anal and Urogenital Squamous Cell Carcinoma: Experience and Outcomes from an Exenteration Unit Over 12 Years
Smith N, Waters PS, Peacock O, Kong JC, McCormick J, Warrier SK, McNally O, Lynch AC, Heriot AG
(2020), Ann Surg Oncol, 27(7), 2450-6
DOI: 10.1245/s10434-020-08229-8
Hybrid abdominal robotic approach with conventional transanal total mesorectal excision (TaTME) for rectal cancer: feasibility and outcomes from a single institution
Nikolic A, Waters PS, Peacock O, Choi CC, Rajkomar A, Heriot AG, Smart P, Warrier S
(2020), Journal of Robotic Surgery, 14(4), 633-41
DOI: 10.1007/s11701-019-01032-y
Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases
Peacock O, Waters PS, Kong JC, Warrier SK, Wakeman C, Eglinton T, Murphy DG, Heriot AG, Frizelle FA, McCormick JJ
(2020), Tech Coloproctol, 24(2), 181-90
DOI: 10.1007/s10151-019-02141-4
Using taTME to maintain restorative options in locally advanced rectal cancer: A technical note
Larach JT, Waters PS, McCormick JJ, Heriot AG, Smart PJ, Warrier SK
(2020), International Journal of Surgery Case Reports, 73, 39-43
DOI: 10.1016/j.ijscr.2020.06.015
Multivisceral, vascular and nodal resection for recurrent rectal cancer involving the left renal tract, left pelvic side wall and abdominal aorta
Wilson K, Waters PS, Peacock O, Heriot AG, Wagner T, Warrier SK
(2020), ANZ J Surg, 90(4), 632-4
DOI: 10.1111/ans.15281
Oxaliplatin versus Mitomycin C following complete cytoreduction for colorectal peritoneal metastases: a comparative study
Narasimhan V, Warrier S, Michael M, Ramsay R, Heriot A
(2020), J Gastrointest Surg, 24(9), 2104-12
DOI: 10.1007/s11605-019-04447-y
Predictors of overall survival following extended radical resections for locally advanced and recurrent pelvic malignancies
Kong JC, Peacock O, Waters PS, Eglinton T, Warrier SK, Wakeman C, Frizelle FA, Heriot AG, McCormick JJ
(2020), LANGENBECK ARCH SURG, 405(4), 491-502
DOI: 10.1007/s00423-020-01895-y
Toxic megacolon due to Salmonella acute infectious colitis requiring total colectomy following loop ileostomy closure
Belvedere S, Foster JD, Soucisse ML, Warrier SK, Heriot AG
(2020), ANZ J Surg, 90(12), E200-1
DOI: 10.1111/ans.15973
Delayed Haemorrhage Following Pelvic Side Wall Excision With Internal Iliac Vessel Resection in Locally Recurrent Rectal Cancer
Hamilton JM, Larach TJ, Heriot AG, Warrier SK, McCormick JJ
(2020), ANZ J Surg, 90(10), 2125-7
DOI: 10.1111/ans.15734
Complications After Extended Radical Resections for Locally Advanced and Recurrent Pelvic Malignancies: A 25-Year Experience
Peacock O, Waters PS, Kong JC, Warrier SK, Wakeman C, Eglinton T, Heriot AG, Frizelle FA, McCormick JJ
(2020), Ann Surg Oncol, 27(2), 409-14
DOI: 10.1245/s10434-019-07816-8
Pelvic sidewall excision with en bloc complete sciatic nerve resection in locally re-recurrent rectal cancer
Lee DJ, Waters PS, Larach JT, McCormick JJ, Heriot AG, Warrier SK
(2020), ANZ J Surg, 90(6), 1202-4
DOI: 10.1111/ans.15512
Complete mesocolic excision and central vascular ligation for right-sided cancers: is it time to jump on board?
Narasimhan V, Das A, Waters P, McCormick J, Heriot A, Warrier S
(2020), ANZ J Surg, 90(1-2), 11-12
DOI: 10.1111/ans.15444
